ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome
Ya-ping Pei(Wuhan University of Science and Technology), Yan Zeng(Wuhan University of Science and Technology)
Cited by 15
Related Papers
Calsyntenin-1 Negatively Regulates ICAM5 Accumulation in Postsynaptic Membrane and Influences Dendritic Spine Maturation in a Mouse Model of Fragile X Syndrome
|Frontiers in Neuroscience|2019|19
<p>Positive correlation between programmed death ligand-1 and p53 in triple-negative breast cancer</p>
|OncoTargets and Therapy|2019|15